Gastric electrical stimulation is safe during pregnancy and delivery: Results from a French cohort
Neurogastroenterology & Motility · 2023-10 · 35 (10)
DOI: 10.1111/nmo.14657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 13.08.2023. Verfasst von Heithem Soliman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hépato-Gastro-Entérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Louis Mourier, DMU ESPRIT-GHU AP-HP-Nord, Colombes, France. Hauptthemen laut MEDLINE: Gastroparesis, Electric Stimulation Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gastric electrical stimulation (GES) is an effective therapy in medically refractory chronic nausea and vomiting. GES is assumed to be a contraindication for pregnancy. We examined the safety of GES during pregnancy and its clinical impact on vomiting symptoms.
Methods
A retrospective study was performed in two tertiary centers including all female patients of childbearing age implanted with GES. Patients without pregnancy while on GES were asked about their desire and concerns about pregnancy. Patients who were pregnant while on GES therapy were interviewed about the course of the pregnancy and labor, as well as the health of the children. Key Results Among 91 patients implanted at childbearing age, 54 patients without pregnancy answered the questionnaire. Nine patients (16.7%) reported a desire for pregnancy and five patients (7.4%) reported worries about the safety of GES during pregnancy. Sixteen pregnancies were reported in 10 patients. All pregnancies ended in a live birth with premature birth in 12 pregnancies (75.0%). No health concern was currently noted in these children. No severe GES‐related complications occurred during pregnancy with only pain at the implantation site reported during 3 pregnancies (18.8%). The severity and frequency of nausea and vomiting significantly increased during the first trimester ( p = 0.04 and p = 0.005, respectively) and decreased after the delivery, becoming lower than before the pregnancy ( p = 0.044 and p = 0.011, respectively). Conclusion & Inferences Patients are concerned regarding pregnancy while being treated with GES. No serious maternal or fetal complications related to GES were noted in our cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service d'Hépato-Gastro-Entérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Louis Mourier, DMU ESPRIT-GHU AP-HP-Nord, Colombes, France.
- Department of Physiology, Université de Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, Rouen, France.
- Department of Gynecology and Obstetrics, HELIOS Kliniken GmbH, Rottweil, Germany.
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.
- Centre de Recherche sur l'Inflammation, Université Paris Cité, INSERM, Paris, France.
- Department of Physiology, Université de Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, CIC-CRB 1404, Rouen, France.
ORCID-Profile: Heithem Soliman, Benoît Coffin, Guillaume Gourcerol
Zitieren
APA
Soliman, H., Schalla, M. A., Coffin, B., & Gourcerol, G. (2023). Gastric electrical stimulation is safe during pregnancy and delivery: Results from a French cohort. Neurogastroenterology & Motility, 35(10). https://doi.org/10.1111/nmo.14657
Vancouver
Soliman H, Schalla MA, Coffin B, Gourcerol G. Gastric electrical stimulation is safe during pregnancy and delivery: Results from a French cohort. Neurogastroenterology & Motility. 2023;35(10). doi:10.1111/nmo.14657
BibTeX
@article{Soliman2023,
author = {Soliman, Heithem and Schalla, Martha A and Coffin, Benoît and Gourcerol, Guillaume},
title = {Gastric electrical stimulation is safe during pregnancy and delivery: Results from a French cohort},
journal = {Neurogastroenterology & Motility},
year = {2023},
volume = {35},
number = {10},
doi = {10.1111/nmo.14657}
}
EUVIMED